| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014651467 |
| P356 | DOI | 10.1186/AR2189 |
| P932 | PMC publication ID | 2072883 |
| P698 | PubMed publication ID | 17767743 |
| P5875 | ResearchGate publication ID | 6072292 |
| P2093 | author name string | Maureen D Mayes | |
| Maria Trojanowska | |||
| P2860 | cites work | Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor | Q22254598 |
| Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation | Q24291689 | ||
| Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond | Q28241686 | ||
| Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis | Q28276277 | ||
| Familial risk estimation in systemic sclerosis | Q33592408 | ||
| Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts | Q34283585 | ||
| Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays | Q34459518 | ||
| Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis | Q34535766 | ||
| Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population | Q35637803 | ||
| Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin | Q35791840 | ||
| An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes | Q36556437 | ||
| Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis | Q36927749 | ||
| Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal | Q40848490 | ||
| The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis | Q42472969 | ||
| Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies | Q42603143 | ||
| Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence | Q44134736 | ||
| Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma | Q44213853 | ||
| Signaling vascular morphogenesis and maintenance | Q45058276 | ||
| Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients | Q45142048 | ||
| Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. | Q45152674 | ||
| Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program | Q45184208 | ||
| PTPN22 and rheumatoid arthritis: gratifying replication | Q46573571 | ||
| Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients | Q46897905 | ||
| The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. | Q51051003 | ||
| An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. | Q53550973 | ||
| Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis. | Q54590489 | ||
| Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. | Q54590559 | ||
| Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. | Q54735421 | ||
| −238 and +489 TNF-α along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis | Q57807781 | ||
| High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis | Q59403027 | ||
| Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts | Q60537787 | ||
| Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway | Q60537820 | ||
| Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy | Q78403797 | ||
| Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population | Q78794905 | ||
| Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts | Q79795007 | ||
| Clinical, immunologic, and genetic features of familial systemic sclerosis | Q80388322 | ||
| Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis | Q81014978 | ||
| Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis | Q81318245 | ||
| Genome-wide meta-analysis for rheumatoid arthritis | Q83151084 | ||
| P921 | main subject | systemic scleroderma | Q5340515 |
| P304 | page(s) | S5 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Genetic factors in systemic sclerosis | |
| P478 | volume | 9 Suppl 2 |
| Q36993225 | A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation |
| Q51170247 | Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis. |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q37417754 | Current developments in pediatric systemic sclerosis |
| Q38868948 | Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability |
| Q37346201 | Epigenetics and dermatological disease |
| Q47905885 | Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis |
| Q37791685 | Fibrosis and immune dysregulation in systemic sclerosis |
| Q37417751 | Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts |
| Q57987460 | Interleukin-10 Gene Promoter and NFKB1 Promoter Insertion/Deletion Polymorphisms in Systemic Sclerosis |
| Q61040882 | Juvenile Localized and Systemic Scleroderma |
| Q54445962 | Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis. |
| Q93900951 | Systemic sclerosis and related connective tissue diseases: present and future |
| Q37305155 | The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis |
| Q35557424 | Vascular involvement in systemic sclerosis (scleroderma). |
Search more.